More info
Novel potent and selective sigma 2 (σ2) receptor agonist, being 20 times more potent than hydroxychloroquine in anti Covid-19 activity in the viral titer assay, while displaying low affinity for the hERG ion channel, with possibly less cardiac side effects than hydroxychloroquine